Healthy volunteers needed to test how common drugs interact with experimental medicine
NCT ID NCT07357610
First seen Jan 23, 2026 · Last updated May 12, 2026 · Updated 17 times
Summary
This early-stage trial in 60 healthy Chinese adults checks how the body processes a new drug (SIM0270) when taken with other medicines like itraconazole, rifampin, or midazolam. The goal is to measure drug levels in the blood, not to treat any disease. Participants must be healthy, aged 18–55, and willing to follow the study schedule.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong University of Qilu Hospital
RECRUITINGJinan, Shandong, 250100, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.